VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Co-targeting PI3K, mTOR, and IGF1R with small molecule inhibitors for treating undifferentiated pleomorphic sarcoma.
Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumors
Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma.
Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic target.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic target.
Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic target. Clin Cancer Res. 2008 Aug 15; 14(16):5033-42.
View in:
PubMed
subject areas
Animals
Blotting, Western
Cell Proliferation
Cytokines
Female
Flow Cytometry
Humans
Immunohistochemistry
Low Density Lipoprotein Receptor-Related Protein-1
Membrane Glycoproteins
Mice
Mice, Nude
Protein Tyrosine Phosphatases
Receptors, Growth Factor
Reverse Transcriptase Polymerase Chain Reaction
Sarcoma
Soft Tissue Neoplasms
Tissue Array Analysis
authors with profiles
ALEXANDER LAZAR